Alpha Score of 59 reflects moderate overall profile with strong momentum, moderate value, moderate quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.
| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Citadel Ken Griffin | 268K | $73.80M | NEW |
| Point72 Steve Cohen | 238K | $65.44M | NEW |
| Renaissance Technologies Jim Simons (founder) | 105K | $28.82M | NEW |
| Marshall Wace | 36K | $9.80M | NEW |
West Pharmaceutical Services, Inc. is a global leader in designing and manufacturing drug packaging and delivery solutions for pharmaceutical, biotechnology, and medical device industries. The company specializes in elastomeric and polymer components that maintain the integrity and safety of injectable medicines, including vial stoppers, syringe plungers, cartridge-based delivery systems, and complete safety-engineered administration devices. Its product portfolio encompasses containment and delivery platforms supporting traditional small-molecule injectables and advanced biologics, along with prefillable syringe systems, custom-engineered polymer components, and integrated safety systems to reduce needlestick injuries and improve patient compliance. West Pharmaceutical Services, Inc. also offers design, testing, and regulatory support to assist customers in accelerating development timelines while meeting global quality standards. Operating through Proprietary Products and Contract-Manufactured Products segments, it manufactures pharmaceuticals, biologics, vaccines, and consumer healthcare products. Founded in 1923 and headquartered in Exton, Pennsylvania, the company maintains manufacturing facilities, R&D centers, and technical service laboratories across North America, Europe, and Asia-Pacific, fostering collaboration with leading drug firms worldwide.
Earnings calendar coming soon. Subscribe to get notified when WST reports next.
Get earnings alerts →